Literature DB >> 16757487

The drug effectiveness review project: an important step forward.

Mark Gibson1, John Santa.   

Abstract

Peter Neumann's paper on the Drug Effectiveness Review Project (DERP) is a constructive if incomplete point of departure for discussing the work done by the project and the use of that work by decision-makers in states and elsewhere. This Perspective attempts to establish the proper context for judging the DERP by comparing its product and processes with those commonly produced and used by industry and other parties. It also provides a direct response to the criticisms of the project noted by Neumann.

Mesh:

Year:  2006        PMID: 16757487     DOI: 10.1377/hlthaff.25.w272

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

1.  "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government.

Authors:  Christopher J Jewell; Lisa A Bero
Journal:  Milbank Q       Date:  2008-06       Impact factor: 4.911

2.  Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces.

Authors:  Steven G Morgan; Paige A Thomson; Jamie R Daw; Melissa K Friesen
Journal:  BMC Health Serv Res       Date:  2013-01-31       Impact factor: 2.655

3.  Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.

Authors:  Olivier J Wouters; Panos G Kanavos; Martin McKEE
Journal:  Milbank Q       Date:  2017-09       Impact factor: 4.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.